These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 354830

  • 1. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D, Boddy K, Brown JJ, Davies DL, Fraser R, Lever AF, Morton JJ, Robertson JI.
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
    [Abstract] [Full Text] [Related]

  • 2. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D, Boddy K, Brown JJ, Davies DL, Fraser R, Lever AF, Morton JJ, Robertson JI.
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
    [Abstract] [Full Text] [Related]

  • 3. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A, Brown JJ, Davies DL, Fraser R, Robertson JI, Lever AF.
    J Hypertens; 1984 Aug 17; 2(4):329-36. PubMed ID: 6530544
    [Abstract] [Full Text] [Related]

  • 6. A comparison of moduretic and hydrochlorothiazide in the treatment of hypertension in African patients.
    Salako LA, Falase AO.
    East Afr Med J; 1973 Jan 17; 50(1):38-47. PubMed ID: 4720446
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K, Krempler F, Sandhofer F.
    Acta Med Austriaca; 1984 Jan 17; 11(2):49-53. PubMed ID: 6377793
    [Abstract] [Full Text] [Related]

  • 9. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT, Melby JC.
    Clin Exp Hypertens A; 1983 Jan 17; 5(6):779-801. PubMed ID: 6309436
    [Abstract] [Full Text] [Related]

  • 10. Amiloride in primary hyperaldosteronism.
    Griffing GT, Cole AG, Aurecchia SA, Sindler BH, Komanicky P, Melby JC.
    Clin Pharmacol Ther; 1982 Jan 17; 31(1):56-61. PubMed ID: 7053305
    [Abstract] [Full Text] [Related]

  • 11. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
    Jørgensen F, Bredesgaard P, Johansen P.
    Pharmatherapeutica; 1986 Jan 17; 4(10):655-64. PubMed ID: 3602017
    [Abstract] [Full Text] [Related]

  • 12. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH, Drayer JI, Smals AG, Kloppenborg PW.
    Clin Pharmacol Ther; 1980 Mar 17; 27(3):317-23. PubMed ID: 6987022
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of arterial hypertension with a combination of hydrochlorothiazide and hydrochloride amiloride].
    da Cunha GP, Albanesi FM, Wajngarten M, Cantarelli EL.
    Arq Bras Cardiol; 1983 May 17; 40(5):353-6. PubMed ID: 6360099
    [No Abstract] [Full Text] [Related]

  • 14. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT, Aurecchia SA, Sindler BH, Melby JC.
    J Clin Pharmacol; 1982 May 17; 22(11-12):505-12. PubMed ID: 6761369
    [Abstract] [Full Text] [Related]

  • 15. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F, Hwang IK, Muccilli AC.
    Clin Ther; 1980 May 17; 3(3):168-75. PubMed ID: 7006811
    [Abstract] [Full Text] [Related]

  • 16. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D, Beevers DG, Brown JJ, Davies DL, Ferriss JB, Fraser R, Lever AF, Robertson JI.
    Clin Sci Mol Med Suppl; 1973 Aug 17; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE, Hettiarachchi J, Fraser R, Morton JJ.
    Clin Pharmacol Ther; 1980 Apr 17; 27(4):533-43. PubMed ID: 7357812
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC, Machado FS, da Silva EP, Lutucuta S, Almeida G, Coucelo J, Vagueiro C.
    Rev Port Cardiol; 1999 Sep 17; 18(9):801-12. PubMed ID: 10536470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.